Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01432132 · ClinicalTrials.gov registry record

Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer

A clinical trial of Head and Neck Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
25
Enrollment target
1
Study location

NCT01432132: Completed study of Head and Neck Cancer, sponsored by M.D. Anderson Cancer Center.

NCT01432132 is a study of Head and Neck Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 25 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01432132, a study of Head and Neck Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to understand how patients adjust to appearance and body image changes after surgery for head and neck cancer.

Primary Outcome

Patients' experiences of viewing themselves in the mirror immediately after surgical treatment for head and neck cancer. Descriptive information derived from 1 hour face-to-face interviews with qualitative methodology using Grounded Theory design and methods with use of constant comparative technique and analysis.

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaire
  • BEHAVIORAL Interview

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2011-08-24
Est. Completion 2017-07-25
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT01432132 record still lists

NCT01432132 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.

NCT01432132 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01432132 about?

NCT01432132 is a clinical study titled "Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer". The goal of this research study is to understand how patients adjust to appearance and body image changes after surgery for head and neck cancer.

What is the current status of trial NCT01432132?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2011-08-24. Estimated completion is 2017-07-25.

What conditions does trial NCT01432132 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT01432132?

The interventions under investigation include: Questionnaire (BEHAVIORAL), Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT01432132?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01432132 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01432132's enrollment target sits among peer trials

25 196th of 250 higher than 47 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01432132, the US trial registry maintained by the National Library of Medicine. NCT01432132 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.